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Abstract
Glucose triggers transcriptional and post-transcriptional mechanisms that increase the amount and the activity of
Saccharomyces cerevisiae plasma membrane H-ATPase. In a previous study, we found that a mutation in the Rsp5
ubiquitin^protein ligase enzyme affected the post-transcriptional activation of the enzyme by glucose. Mutations at the RSP5
locus alter the glucose-triggered Km decrease. In a genetic screening for multicopy suppressors of the rsp5 mutation, we
identified the WSC2/YNL283c gene. Deletion of the WSC2 gene disturbs ATPase activation by glucose, abolishing the Km
decrease that occurs during this process. Wsc2 is a component of the PKC1-MPK1 mitogen-activated protein kinase
(MAPK) signaling pathway that controls the cell wall integrity. Deletion of the MPK1/SLT2 gene disturbs the glucose-
triggered Km decrease in ATPase. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The plasma membrane H-ATPase of yeast is a
proton pump that plays an essential role in the phys-
iology of this organism [1^4]. The activity of the
yeast ATPase is regulated at both transcriptional
and post-translational levels by a large number of
environmental factors [5]. Glucose is the most exten-
sively investigated external signal. The activity of the
ATPase is controlled in at least in two ways by the
presence of glucose in the medium. First, glucose
metabolism increases PMA1 mRNA synthesis [6,7]
and second, glucose induces ATPase activation [8].
This activation results from a combined e¡ect on the
kinetic parameters of the enzyme, including Km de-
crease, Vmax increase and optimum pH shift to neu-
tral value [8]. These alterations in the kinetic param-
eters are probably the consequence of more e⁄cient
enzyme coupling [9].
Although the molecular mechanism of the glucose-
induced activation appears to be based on elimina-
tion of an inhibitory interaction of the C-terminus
with the enzyme active site [10^12], the signal that
triggers this mechanism is unknown. This activation
is probably mediated by Ser/Thr phosphorylation
[13] by an unknown protein kinase. Two regulatory
sites, located at the C-terminus and de¢ned by the
phosphorylatable amino acids Ser-899 and Thr-912,
are essential for the glucose-induced Km and Vmax
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changes, respectively [12]. The glucose activation of
the enzyme seems to be prevented by a glucose star-
vation-dependent, YCK-mediated phosphorylation
of Pma1 [14].
In an earlier study, we isolated mutants in the
Rsp5 ubiquitin^protein ligase that a¡ected the glu-
cose-triggered Km decrease of the ATPase [15]. In a
search for multicopy suppressors of the rsp5 muta-
tion, we found that overexpression of WSC2 rescues
the rsp5 mutant ATPase activation defects. WSC2
has been proposed in the Pkc1-Bck1-Mkk1/2-Mpk1
mitogen-activated protein kinase (MAPK) cascade
[16,17]. The Pkc1^Mpk1 cascade is involved in cell
wall remodeling [18]. We show that two other com-
ponents of the pathway, BCK1 and MPK1, are also
required for the glucose-triggered Km decrease of the
ATPase.
2. Materials and methods
2.1. Strains and growth conditions
Saccharomyces cerevisiae strains BWG1^7A
(MATa ade1^100 his4^519 leu2^3,112 ura3^52) [19],
H19 (BWG1^7A rsp5) [15], and its derivatives were
grown in medium with 2% glucose, 0.7% yeast nitro-
gen base without amino acids (US Biologicals,
Swampscott, MA) and the appropriate requirements
[20]. When indicated, medium was bu¡ered with 50
mM Mes adjusted to pH 6.0 with Tris (SD6.0), or
with 50 mM succinic acid adjusted to pH 3.0 with
Tris (SD3.0).
2.2. Genetic screen
Yeast strain H19 carrying the rsp5 mutation was
transformed [21] with 50 Wg of DNA from a YEp24-
based library [22]. Approximately 15, 00 transform-
ants were selected in SD6.0 medium. Transformed
cells were pooled and plated in SD3.0 medium. After
four days at 30‡C, ¢ve colonies grew on acidic me-
dium. Biochemical analysis of these strains showed
that all exhibited wild-type ATPase levels. Plasmids
were rescued from yeast [23] and ampli¢ed in Esche-
richia coli. Restriction analysis and partial sequenc-
ing of these clones revealed that all plasmids con-
tained the same insert (Fig. 1).
Deletion of the WSC2 was performed using the
materials and procedure of the EUROFAN (Euro-
pean Functional Analysis Network) [24]. The re-
placement reporter cassette encoding the Kanr gene
was prepared using speci¢c primers in PCR and used
to transform an autodiploid constructed by transfor-
mation of strain BWG1^7A with the HO gene [25].
Integration of the wsc2v : :KanMX4 construct at the
WSC2 locus was con¢rmed by PCR. The heterozy-
gous diploid wsc2v : :KanMX4/WSC2 was sporu-
lated, and tetrads were dissected.
2.3. Biochemical methods
Yeast plasma membrane was puri¢ed from glu-
cose-starved and glucose-fermenting cells by di¡er-
ential and sucrose gradient centrifugation [8]. ATP-
ase activity was assayed at pH 6.5 with ATP
concentrations from 0.8 to 6 mM and the concentra-
Fig. 1. Chromosomal location and subcloning of the WSC2 gene. Restriction map of a region of chromosome XIV [16]. Arrows indi-
cate positions of the ORFs. Thin horizontal lines represent DNA subclones used to test the ability to complement the rsp5 mutation.
Restriction enzyme sites: K, KpnI; S, SalI; Sp, SphI X, XbaI; Xh, XhoI.
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tion of free Mg2 was 1 mM [26]. The apparent Km
and Vmax were extrapolated from double-reciprocal
plots ¢tted using a standard least-squares method.
Similar values (within 10%) were obtained with two
di¡erent plasma membrane preparations isolated in-
dependently. Protein concentration was determined
by the Bradford method [27] using the Bio-Rad pro-
tein assay reagent and bovine IgG as standard.
3. Results and discussion
3.1. Isolation of WSC2
We previously described a rsp5 mutant defective in
the glucose activation-triggered Km decrease of the
ATPase [15]. This strain exhibits slow growth on
SD3.0 medium as a consequence of the diminished
plasma membrane ATPase activity. To gain insight
into the mechanism of ATPase regulation by the
Rsp5 ubiquitin^protein ligase enzyme, we screened
for genes that confer on the rsp5 mutant the ability
to grow on SD3.0 when present in a episomal plas-
mid. After transformation of the recipient strain with
a YEp24-based genomic library, we recovered one
plasmid (pNF01^100, Fig. 1). This plasmid comple-
mented the slow growth phenotype of the mutant
and restored the wild-type ATPase activity level. Par-
tial sequence analysis showed that the complement-
ing insert corresponds to a region of chromosome
XIV (Fig. 1). Subcloning experiments indicated that
only the region containing WSC2 was required for
complementation. We next analyzed the e¡ect of
WSC2 carried in a multicopy plasmid on the kinetic
parameters of ATPase from glucose-starved and glu-
cose-fermenting wild-type and rsp5 mutant cells. The
results showed that WSC2 overexpression in a rsp5
mutant strain restored the glucose-triggered Km de-
crease of the ATPase (Table 1).
3.2. WSC2 gene deletion a¡ects glucose-triggered
plasma membrane ATPase activation
WSC2 belongs to a family of genes (WSC1^
Table 1














BWG1-7A Wild type None 4.0 0.3 0.9 1.2
H19 rsp5 None 4.5 0.5 5.0 1.1
BWG/W Wild type WSC2 4.0 0.3 1.0 1.4
H19/W rsp5 WSC2 5.0 0.4 1.5 1.2
GS, glucose-starved cells ; GF, glucose-fermenting cells. Cells were grown, collected and treated with glucose as described [10].
Table 2
Kinetic parameters of ATPase from glucose-starved and glucose-fermenting wild-type and wsc2v mutant cells









Wild type None 4.0 0.2 1.1 1.1
wsc2v None 4.0 0.4 4.0 1.0
wsc2v WSC1 4.0 0.3 2.0 1.3
wsc2v WSC2 4.5 0.4 1.0 1.9
wsc2v WSC3 4.0 0.4 1.5 1.2
wsc2v RSP5 5.0 0.3 1.5 1.0
GS, glucose-starved cells ; GF, glucose-fermenting cells. Cells were grown, collected and treated with glucose as described [10].
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WSC4) that encode predicted integral membrane
proteins with a conserved cysteine motif [16]. Genetic
analysis suggested that the WSC gene family might
mediate intracellular responses to environmental
stress through di¡erent signaling pathway [16]. This
prompted us to further characterize the e¡ect of
WSC2 on activation of the ATPase. To this end,
we generated a mutant strain lacking WSC2, and
analyzed the kinetic properties of the ATPase in pu-
ri¢ed plasma membrane of glucose-starved and glu-
cose-fermenting wild-type and mutant strain (Table
2). In the wsc2v mutant, the characteristics glucose-
induced Km decrease was not observed, suggesting
that WSC2 is required for ATPase activation. In ad-
dition, the fact that WSC1 or WSC3 expressed in
multicopy plasmid partially suppressed the pheno-
type of the wsc2v mutant (Table 2) also suggests
that WSC genes may have overlapping functions.
To further characterize the genetic interaction be-
tween WSC2 and RSP5, we tested the phenotype of
strains with a WSC2 gene deletion in combination
with RSP5 expressed in a multicopy vector. Overex-
pression of RSP5 suppressed the phenotype of the
wsc2v mutant (Table 2). This epistasis analysis and
the fact that WSC2 suppresses the rsp5 mutation
suggest that WSC2 and RSP5 de¢ne two independ-
ent pathways that may have overlapping functions in
the regulation of ATPase activation.
3.3. MPK1/SLT2 requirement for ATPase activation
Genetic data suggested that WSC genes interact
with both the Ras^cAMP and the PKC1^MPK1 sig-
naling pathways to mediate the stress response [16].
Since glucose-induced activation of ATPase is not
mediated by the cAMP-dependent protein kinase A
[28,29], we studied whether the PKC1^MPK1 kinase
cascade is involved in the activation of ATPase. We,
¢rst tested the phenotype of strains with a WSC2
gene deletion that overexpressed protein kinases act-
ing in di¡erent signaling pathways, such as Mpk1
and Bck1 (cell wall remodeling), Fus3 (mating),
Kss1 (¢lamentation), and Hog1 (osmolyte synthesis).
The results showed that only overexpression of
MPK1 and BCK1 suppressed the phenotype of the
wsc2v mutant (Table 3). We next studied the pheno-
type of strains with a deletion of the MPK1, BCK1,
FUS3, KSS1 or HOG1 gene, and found that mpk1v
and bck1v mutations abolished the glucose activa-
tion-triggered ATPase Km decrease (Table 3).
3.4. Phenotype of the wsc2 and mpk1 mutants
To study the consequences of the WSC2 and
MPK1 gene deletions on the in vivo ATPase activity,
we examined the proton pumping activity and the
tolerance to hygromycin B of the wsc2v and
Table 3
E¡ect of MAPK cascades genes on kinetic parameters of ATPase from glucose-starved and glucose-fermenting cells









Wild type None 4.0 0.2 1.1 1.1
wsc2v None 4.0 0.4 4.0 1.2
wsc2v WSC2 4.0 0.3 1.5 1.3
wsc2v MPK1 4.5 0.4 1.0 1.6
wsc2v BCK1 4.0 0.4 1.5 1.2
wsc2v FUS3 5.0 0.3 4.0 1.0
wsc2v KSS1 5.0 0.3 4.5 1.1
wsc2v HOG1 4.0 0.4 4.0 1.2
mpk1v None 5.0 0.3 4.5 1.3
bck1v None 5.0 0.3 4.0 1.0
fus3v None 5.0 0.2 1.5 1.4
kss1v None 4.5 0.3 1.0 1.0
hog1v None 5.0 0.4 1.5 1.1
bck1v MPK1 5.0 0.3 1.0 1.4
GS, glucose-starved cells ; GF, glucose-fermenting cells. Cells were grown, collected and treated with glucose as described [10].
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mpk1v mutant cells. Yeast cells actively extrude pro-
tons into the medium, an activity caused by plasma
membrane H-ATPase, which re£ects the in vivo
activity of the enzyme [30]. On the other hand, mu-
tants with ATPase decreased activity are resistant to
the aminoglycoside antibiotic hygromycin B. The
antibiotic tolerance results from a decreased uptake
of the toxic cation due to depolarization of cellular
membrane [31^33]. Table 4 shows that wsc2vand
mpk1v mutant cells exhibited both a lower H-
pumping activity and an increased resistance to hy-
gromycin B relative to the wild-type strain. These
results suggest that the deletion of the WSC2 and
MPK1 genes cause a decrease of the in vivo ATPase
activity.
Overall, the present results suggest that the Wsc2-
Pkc1-Bck1-Mkk1/2-Mpk1 MAPK cascade mediates
the activation of the ATPase by glucose.
In the ¢ssion yeast Schizosaccharomyces pombe,
the Spm1/Pmk1 is the putative homologue of the
budding yeast Mpk1/Slt2 MAP kinase [35]. SPM1
deletion has no noticeable e¡ect on ATPase activa-
tion, but when it is combined with a deletion of the
non-essential Pzh1 protein phosphatase gene, a se-
vere decrease in the ATPase activity is observed
[36]. Although a kinetic analysis of the ATPase
from the double mutant is not available, these data
could suggest that Spm1 has a function in controlling
ATPase activity in S. pombe, resembling that of its
counterpart in the budding yeast.
Whether Mpk1 regulates the ATPase directly or
indirectly remains to be analyzed. As mentioned
above, it has been proposed that the glucose-induced
activation of the ATPase to be mediated by Ser/Thr
phosphorylation [13]. Ser 899, located in the regula-
tory domain of the ATPase, is a phosphorylatable
site involved in the glucose-induced Km decrease
[12]. One obvious possibility is thus that Mpk1 phos-
phorylates Ser-899 to induce the Km decrease; an
additional model is that Mpk1 function controls
the expression and/or activity of protein(s) involved
in ATPase activation. At present, we cannot discern
between these two alternatives.
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